Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BLUE crawled time : 01:00 save search
Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Published: 2023-03-06 (Crawled : 01:00) - biospace.com/
TSVT | $4.63 -0.43% -0.43% 290K
|
|
| O: 0.43%
H: 1.03%
C: -4.82%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.1%
H: 0.42%
C: -0.68%
INBX | $34.09 -0.03% -0.03% 250K
|
Health Technology
|
| O: -0.37%
H: 1.79%
C: -1.62%
BLUE | $0.9739 2.13% 2.08% 4.8M
|
Health Technology
|
| O: 1.96%
H: 0.96%
C: -5.59%
year financial results
bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood Cell Transfusions
Published: 2021-09-21 (Crawled : 01:00) - biospace.com/
BLUE | $0.9739 2.13% 2.08% 4.8M
|
Health Technology
|
| O: 0.0%
H: 1.56%
C: 0.11%
fda blood gene therapy therapy license gene therapies cel
Kymera Therapeutics Appoints Karen Weisbach as Vice President, People and Culture and Jolly Bhatia as Vice President, Quality
Published: 2021-07-29 (Crawled : 01:00) - biospace.com/
XFOR | $1.225 -9.93% -11.02% 3.5M
|
Health Technology
|
| O: 0.0%
H: 5.18%
C: 3.97%
KYMR | $35.7 3.93% 3.78% 440K
|
Health Technology
|
| O: 0.25%
H: 0.99%
C: -3.88%
BLUE | $0.9739 2.13% 2.08% 4.8M
|
Health Technology
|
| O: 0.85%
H: 1.64%
C: -2.14%
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
|
| O: -0.01%
H: 1.3%
C: -0.14%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.